An Entity of Type: Thing, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden, the Public Health Agency has been commissioned by the government to create a vaccination plan. Sveriges riksbank, the central bank of Sweden, predicts that efficient vaccination against COVID-19 has macroeconomic benefits. As of 20 April 2022, 87.1% of people (12 years and older) in Sweden have received at least one dose, with a total of 21,491,717 doses administered.At least one vaccine has been approved for all age groups 12 and older. Children younger than 12 in high risk groups can also be vaccinated.

Property Value
dbo:abstract
  • Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden, the Public Health Agency has been commissioned by the government to create a vaccination plan. Sveriges riksbank, the central bank of Sweden, predicts that efficient vaccination against COVID-19 has macroeconomic benefits. As of 20 April 2022, 87.1% of people (12 years and older) in Sweden have received at least one dose, with a total of 21,491,717 doses administered.At least one vaccine has been approved for all age groups 12 and older. Children younger than 12 in high risk groups can also be vaccinated. (en)
  • Covid-19-vaccinationskampanjen i Sverige är en pågående massimmuniseringskampanj för att tackla covid-19-pandemin i Sverige. Vaccinationskampanjen inleddes den 27 december 2020 i Sverige. Fram till den 22 december 2022 hade 88,2 procent av den svenska befolkningen över 18 år vaccinerats med minst en dos, totalt hade25 469 958 doser administrerats. Den 29 juli 2021 hade varannan vuxen svensk blivit fullvaccinerad med två doser. (sv)
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 66306149 (xsd:integer)
dbo:wikiPageLength
  • 26543 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1096061411 (xsd:integer)
dbo:wikiPageWikiLink
dbp:caption
  • 0001-04-20 (xsd:gMonthDay)
dbp:cause
dbp:date
  • 2020-12-27 (xsd:date)
dbp:location
dbp:nativeName
  • Vaccination mot covid-19 (en)
dbp:nativeNameLang
  • sv (en)
dbp:organisers
dbp:outcome
  • 81.100000 (xsd:double)
  • 85.300000 (xsd:double)
dbp:participants
  • 17049272 (xsd:integer)
  • : (en)
dbp:title
  • COVID-19 vaccination in Sweden (en)
dbp:website
dbp:wikiPageUsesTemplate
dcterms:subject
rdfs:comment
  • Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden, the Public Health Agency has been commissioned by the government to create a vaccination plan. Sveriges riksbank, the central bank of Sweden, predicts that efficient vaccination against COVID-19 has macroeconomic benefits. As of 20 April 2022, 87.1% of people (12 years and older) in Sweden have received at least one dose, with a total of 21,491,717 doses administered.At least one vaccine has been approved for all age groups 12 and older. Children younger than 12 in high risk groups can also be vaccinated. (en)
  • Covid-19-vaccinationskampanjen i Sverige är en pågående massimmuniseringskampanj för att tackla covid-19-pandemin i Sverige. Vaccinationskampanjen inleddes den 27 december 2020 i Sverige. Fram till den 22 december 2022 hade 88,2 procent av den svenska befolkningen över 18 år vaccinerats med minst en dos, totalt hade25 469 958 doser administrerats. Den 29 juli 2021 hade varannan vuxen svensk blivit fullvaccinerad med två doser. (sv)
rdfs:label
  • COVID-19 vaccination in Sweden (en)
  • Covid-19-vaccinering i Sverige (sv)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:homepage
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License